PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-1.06%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-8.26%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-28.41%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-36.83%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-31.02%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-29.31%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-29.31%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
-0.00%
Share reduction while 3391.T is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.00%
Reduced diluted shares while 3391.T is at 0.13%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-394.70%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-2595.86%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
11.78%
10Y revenue/share CAGR 1.25-1.5x 3391.T's 9.21%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
11.78%
5Y revenue/share CAGR 1.25-1.5x 3391.T's 9.21%. Bruce Berkowitz would verify if cost efficiency or pricing power supports this advantage.
11.78%
3Y revenue/share CAGR 1.25-1.5x 3391.T's 9.21%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-195.64%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-195.64%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
-195.64%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
34.67%
Net income/share CAGR above 1.5x 3391.T's 6.38% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
34.67%
5Y net income/share CAGR above 1.5x 3391.T's 6.38%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
34.67%
3Y net income/share CAGR above 1.5x 3391.T's 6.38%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
22.00%
10Y equity/share CAGR above 1.5x 3391.T's 9.02%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
22.00%
5Y equity/share CAGR above 1.5x 3391.T's 9.02%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
22.00%
3Y equity/share CAGR above 1.5x 3391.T's 9.02%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.